 <h1>Zonegran Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>zonisamide</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about zonisamide. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Zonegran.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to zonisamide: oral capsule</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, zonisamide (the active ingredient contained in Zonegran) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking zonisamide:</p><p>
<i>More common</i>
</p><ul>
<li>Discouragement</li>
<li>double vision</li>
<li>feeling sad or empty</li>
<li>irritability</li>
<li>lack of appetite</li>
<li>loss of interest or pleasure</li>
<li>mood or mental changes</li>
<li>shakiness or unsteady walking</li>
<li>tiredness</li>
<li>trouble with concentrating</li>
<li>trouble with sleeping</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Agitation</li>
<li>bruising</li>
<li>delusions</li>
<li>hallucinations</li>
<li>large, flat blue or purplish patches on the skin</li>
<li>rash</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blurred vision</li>
<li>change in near or distance vision</li>
<li>difficulty in focusing eyes</li>
<li>eye pain</li>
<li>increase in frequency of seizures</li>
<li>swelling of the face</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of zonisamide may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>anxiety</li>
<li>diarrhea</li>
<li>difficulty with memory</li>
<li>dizziness</li>
<li>double vision</li>
<li>headache</li>
<li>loss of appetite</li>
<li>nausea</li>
<li>restlessness</li>
<li>sleepiness</li>
<li>unusual drowsiness</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Aching muscles or joints</li>
<li>acid or sour stomach</li>
<li>bad, unusual, or unpleasant taste in the mouth</li>
<li>belching</li>
<li>change in taste</li>
<li>chills</li>
<li>constipation</li>
<li>difficulty with speaking</li>
<li>difficulty with thinking</li>
<li>dry mouth</li>
<li>fever</li>
<li>general ill feeling</li>
<li>headache</li>
<li>heartburn</li>
<li>indigestion</li>
<li>mental slowness</li>
<li>nervousness</li>
<li>runny or stuffy nose</li>
<li>sneezing</li>
<li>tingling, burning, or prickly feelings on the skin</li>
<li>uncontrolled, back and forth, or rolling eye movements</li>
<li>weight loss</li>
</ul><p>
<!-- end oral capsule --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to zonisamide: oral capsule</i></p><h3>General</h3><p>The most common adverse reactions to this drug are somnolence, dizziness, and anorexia.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Anorexia (13%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, nausea, diarrhea, dyspepsia, constipation, dry mouth<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Somnolence (17%), dizziness (13%), headache (10%), ataxia</p>
<p><b>Common</b> (1% to 10%): Paresthesia, fatigue, tiredness, bradyphrenia, tremor</p>
<p><b>Uncommon</b> (0.1% to 1%): Convulsion</p>
<p><b>Very rare</b> (less than 0.01%): Coma, grand mal seizure, myasthenic syndrome, neuroleptic malignant syndrome, status epilepticus</p>
<p><b>Postmarketing reports</b>: Restless legs syndrome<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Speech abnormalities, difficulties in verbal expression, taste perversion<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Agitation, irritability, confusional state, depression</p>
<p><b>Common</b> (1% to 10%): Difficulty concentrating, difficulty with memory, mental slowing, insomnia, anxiety, nervousness, affect lability, psychotic disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Anger, aggression, suicidal ideation, suicide attempt</p>
<p><b>Very rare</b> (less than 0.01%): Hallucination, amnesia, mania<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Nystagmus, diplopia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Very rare</b> (less than 0.01%): Drug rash with eosinophilia and systemic symptoms, anhidrosis, erythema multiforme, pruritus, Stevens-Johnson syndrome, toxic epidermal necrolysis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia</p>
<p><b>Common</b> (1% to 10%): Weight loss</p>
<p><b>Very rare</b> (less than 0.01%): Metabolic acidosis</p>
<p><b>Postmarketing reports</b>: Elevated creatine phosphokinase<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Ecchymosis </p>
<p><b>Very rare</b> (less than 0.01%): Agranulocytosis, aplastic anemia, leukocytosis, leucopenia, lymphadenopathy, pancytopenia, thrombocytopenia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Pneumonia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection</p>
<p><b>Postmarketing reports</b>: Acute pancreatitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Postmarketing reports</b>: Rhabdomyolysis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity</p>
<p><b>Very rare</b> (less than 0.01%): Drug induced hypersensitivity syndrome<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza syndrome<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Renal tubular acidosis</p>
<p><b>Frequency not reported</b>: Nephrolithiasis, hydronephrosis, renal failure, urine abnormality<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Zonegran (zonisamide)" Elan Pharmaceuticals, S. San Francisco, CA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Zonegran (zonisamide)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>56 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: carbonic anhydrase inhibitor anticonvulsants</li>
<li>FDA Alerts (3)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Zonegran &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Migraine Prevention</li>
<li>Benign Essential Tremor</li>
<li>Parkinsonian Tremor</li>
<li>Seizures</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to zonisamide: oral capsule</i></p><h3>General</h3><p>The most common adverse reactions to this drug are somnolence, dizziness, and anorexia.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Anorexia (13%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, diarrhea, dyspepsia, constipation, dry mouth<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Somnolence (17%), dizziness (13%), headache (10%), ataxia</p><p><b>Common</b> (1% to 10%): Paresthesia, fatigue, tiredness, bradyphrenia, tremor</p><p><b>Uncommon</b> (0.1% to 1%): Convulsion</p><p><b>Very rare</b> (less than 0.01%): Coma, grand mal seizure, myasthenic syndrome, neuroleptic malignant syndrome, status epilepticus</p><p><b>Postmarketing reports</b>: Restless legs syndrome<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Speech abnormalities, difficulties in verbal expression, taste perversion<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Agitation, irritability, confusional state, depression</p><p><b>Common</b> (1% to 10%): Difficulty concentrating, difficulty with memory, mental slowing, insomnia, anxiety, nervousness, affect lability, psychotic disorder</p><p><b>Uncommon</b> (0.1% to 1%): Anger, aggression, suicidal ideation, suicide attempt</p><p><b>Very rare</b> (less than 0.01%): Hallucination, amnesia, mania<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Nystagmus, diplopia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Very rare</b> (less than 0.01%): Drug rash with eosinophilia and systemic symptoms, anhidrosis, erythema multiforme, pruritus, Stevens-Johnson syndrome, toxic epidermal necrolysis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia</p><p><b>Common</b> (1% to 10%): Weight loss</p><p><b>Very rare</b> (less than 0.01%): Metabolic acidosis</p><p><b>Postmarketing reports</b>: Elevated creatine phosphokinase<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Ecchymosis </p><p><b>Very rare</b> (less than 0.01%): Agranulocytosis, aplastic anemia, leukocytosis, leucopenia, lymphadenopathy, pancytopenia, thrombocytopenia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis</p><p><b>Uncommon</b> (0.1% to 1%): Pneumonia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection</p><p><b>Postmarketing reports</b>: Acute pancreatitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Postmarketing reports</b>: Rhabdomyolysis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity</p><p><b>Very rare</b> (less than 0.01%): Drug induced hypersensitivity syndrome<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza syndrome<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Renal tubular acidosis</p><p><b>Frequency not reported</b>: Nephrolithiasis, hydronephrosis, renal failure, urine abnormality<sup>[Ref]</sup></p><p id="ref_1">1. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Zonegran (zonisamide)" Elan Pharmaceuticals, S. San Francisco, CA. </p><h2>More about Zonegran (zonisamide)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>56 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: carbonic anhydrase inhibitor anticonvulsants</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Zonegran &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Migraine Prevention</li>
<li>Benign Essential Tremor</li>
<li>Parkinsonian Tremor</li>
<li>Seizures</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>